SCHEMBL5990835

SCHEMBL5990835

FC(F)(F)c1cccc(OCOCc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.56
NR4A2 P43354 2/20 0.52
MAOB P27338 5/20 0.51
PPARG P37231 1/20 0.50
PPARA Q07869 1/20 0.50
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
IDO1 P14902 2/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
FFAR1 O14842 1/20 0.47
FFAR4 Q5NUL3 1/20 0.47
PKM P14618 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5025938 0.87 MRGPRX4 (0.69) MRGPRX4NR4A2MAOBPPARGPPARA
SCHEMBL6231474 0.82 MRGPRX4 (0.63) MRGPRX4NR4A2MAOB
SCHEMBL10536447 0.81 MRGPRX4 (0.52) MRGPRX4NR4A2PPARGPPARAKDM4E
SCHEMBL5669711 0.81 MAOB (0.74) MRGPRX4NR4A2MAOBL3MBTL1IDO1
SCHEMBL30810364 0.80 IDO1 (0.66) NR4A2MAOBIDO1KMT2AFFAR1
SCHEMBL3158759 0.80 TSHR (0.64) NR4A2MAOBL3MBTL1IDO1LMNA
SCHEMBL12072717 0.80 L3MBTL1 (0.60) MRGPRX4MAOBPPARGPPARAKDM4E
SCHEMBL11019942 0.78 DRD2 (0.55) NR4A2MAOBKDM4EALDH1A1L3MBTL1
SCHEMBL10335673 0.78 MAOB (0.65) MRGPRX4NR4A2MAOBLMNAPKM
SCHEMBL16024758 0.77 L3MBTL1 (0.50) MRGPRX4MAOBKDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660431-A2 PHENOXYACETIC ACID DERIVATIVES Astrazeneca AB (SE) 2006-05-31 EP disclosed
WO-2005018529-A2 PHENOXIACETIC ACID DERIVATIVES ASTRAZENECA AB (SE) 2005-03-03 WO disclosed